SPLENDRIS - Trademark Details
Status: 709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Serial Number
79136686
Registration Number
4642937
Word Mark
SPLENDRIS
Status
709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Status Date
2021-06-11
Filing Date
2013-05-07
Registration Number
4642937
Registration Date
2014-11-25
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2014-09-09
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
COLEMAN, NICHOLAS A
Statements
Description of Mark
The mark is a coinage word and has no special meaning.
Goods and Services
Pharmaceutical preparations, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Chemico-pharmaceutical preparations, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Chemical preparations for pharmaceutical purposes, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Medicines for human purposes, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Medicated troches, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Prepared Chinese medicines, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Biochemical medicines, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Dietetic substances adapted for medical use, namely, beverages or food in the nature of vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, and mineral food-supplements, which are used for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Drugs for medical purposes, namely, medicines for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2021-06-11
Primary Code
005
Correspondences
Name
TIMOTHY T. WANG
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1177009
International Registration Date
2013-05-07
International Publication Date
2013-10-17
International Renewal Date
2023-05-07
Auto Protection Date
2021-01-04
International Status
001 - Request for extension of protection established
International Status Date
2013-10-10
Priority Claimed In
False
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2013-10-10 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2013-10-12 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2013-10-13 | ASSIGNED TO EXAMINER |
| 2013-10-16 | APPLICATION FILING RECEIPT MAILED |
| 2013-10-20 | NON-FINAL ACTION WRITTEN |
| 2013-10-21 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2013-10-22 | REFUSAL PROCESSED BY MPU |
| 2013-10-23 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2013-11-14 | REFUSAL PROCESSED BY IB |
| 2013-11-20 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2013-11-20 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2013-11-20 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2013-12-16 | FINAL REFUSAL WRITTEN |
| 2013-12-17 | FINAL REFUSAL MAILED |
| 2014-06-11 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2014-06-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2014-06-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2014-07-27 | EXAMINERS AMENDMENT -WRITTEN |
| 2014-07-27 | EXAMINERS AMENDMENT E-MAILED |
| 2014-07-27 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2014-07-27 | EXAMINER'S AMENDMENT ENTERED |
| 2014-07-27 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2014-08-05 | ASSIGNED TO LIE |
| 2014-08-05 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2014-08-07 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2014-08-20 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2014-09-09 | PUBLISHED FOR OPPOSITION |
| 2014-09-09 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2014-11-25 | REGISTERED-PRINCIPAL REGISTER |
| 2015-02-25 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2015-03-12 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2015-04-20 | FINAL DISPOSITION PROCESSED |
| 2015-04-20 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2015-05-08 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 2018-12-07 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2019-07-04 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2019-07-05 | CORRECTION TRANSACTION RECEIVED FROM IB |
| 2019-10-09 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| 2019-11-25 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 2021-06-11 | CANCELLED SECTION 71 |
| 2022-02-11 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
